SANTA ANA, CA, Clinical-stage biopharmaceutical company focused on the development of novel immunotherapies, today announced the closing of a $22 million Series C. Read More
CAMBRIDGE, MA, Clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies, has closed an oversubscribed $63M Series B. Read More
SUNNYVALE, CA, Leader in enterprise Revenue Ops, today announced it has secured $27.5 million in financing led by new investor Tenaya Capital. Read More